A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2009
12/02/2009	CN100563645C Beisalutin sustained-release implantation agent for curing entity tumour
12/02/2009	CN100563644C Carmustine sustained-release implantation agent for curing entity tumour
12/02/2009	CN100563640C Method for preparing micro-spheres using modified ploylactic acid material as shell material
12/02/2009	CN100563639C Formulation of red rice and preparation process thereof
12/02/2009	CN100563638C Nifedipine controlled-releasing tablet and preparation method thereof
12/02/2009	CN100563637C A medicine core composition of controlled release drug delivery and controlled release preparation as well as its preparing method
12/02/2009	CN100563636C Acemetacin sustained-release preparation and preparation method
12/02/2009	CN100563635C Drop pills of healthy energy of wrinkled gianthyssop
12/02/2009	CN100563634C Drop pills of medical broth of small bupleurum root
12/02/2009	CN100563633C Hydrochloric acid diltiazem freeze-dried powder injection for injections and preparation method thereof
12/02/2009	CN100563632C Fleraxacin for injection and preparation method thereof
12/02/2009	CN100563631C Shenfu freezing-dried powder injection and its preparation method
12/02/2009	CN100563630C Preparation method of traditional medicine preparation for treating women's menoxenia
12/02/2009	CN100563629C Compound turmeric acne-eliminating gel and its preparation
12/02/2009	CN100563628C Bendalysine eye gel preparation and its making method
12/02/2009	CN100563466C Beverages containing plant sterols
12/01/2009	US7625928 Prevent, therapy of side effect of radiotherapy; applying to skins, mucous membranes
12/01/2009	US7625875 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
12/01/2009	US7625865 Insulin highly respirable microparticles
12/01/2009	US7625620 Tapes or compresses for analgesic, cosmetic or therapeutic use; skin safe, good feel, good acting and cooling effects, easily torn to desired size; perforated yarn support with a paste and release film
12/01/2009	US7625588 Continuous process for production of oil seed protein isolate
12/01/2009	US7625585 Method of attenuating neurogenic bruise formation
12/01/2009	US7625584 Isolating and stabilizing antihemophila factor for use in dosage cancentration for treatment of hemophlia
12/01/2009	US7625582 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
12/01/2009	US7625581 Porous substrate comprising a biodegradable, hydrophobic polymer and a hyaluronic acid complex incorporated with the substrate, wherein the hyaluronic acid complex is insoluble in water, yet soluble in mixtures of organic and aqueous solvents in which the hydrophobic polymer is soluble
12/01/2009	US7625574 Moisturizers; transdermal absorption; ethylene oxide-propylene oxide adduct
12/01/2009	US7625507 Extrusion/melt-congeal process; reduced drug degradation
12/01/2009	US7625446 High temperature high pressure capsule for processing materials in supercritical fluids
12/01/2009	CA2594576C Transcutaneous delivery means
12/01/2009	CA2572461C Physiological compatible film
12/01/2009	CA2523246C Formation of strong superporous hydrogels
12/01/2009	CA2442311C Amorphous cefditoren pivoxil composition and process for producing the same
12/01/2009	CA2422424C Pharmaceutical compositions for rectal and vaginal administration
12/01/2009	CA2407210C Liposome drug delivery
12/01/2009	CA2399426C Endoparasiticidal gel composition
12/01/2009	CA2376593C Method of particle formation
12/01/2009	CA2315237C Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
12/01/2009	CA2305533C Multilamellar coalescence vesicles (mlcv) containing biologically active compounds
11/2009
11/26/2009	WO2009143288A1 Biodegradable sustained-release polymeric microparticulates comprising a hydrophobic drug and determined for ophthalmic use
11/26/2009	WO2009143209A1 Dual opioid pain therapy
11/26/2009	WO2009143175A2 Sensory-specific local anesthesia and prolonged duration local anesthesia
11/26/2009	WO2009143070A1 Treatment of dysmenorrhea via transdermal administration of nonsteroidal anti-inflammatory drugs
11/26/2009	WO2009143064A2 Rice bran extracts for inflammation and methods of use thereof
11/26/2009	WO2009143011A1 Antiviral compositions, methods of making and using such compositions, and systems for pulmonary delivery of such compositions
11/26/2009	WO2009142988A2 Chitin micro-particles as an adjuvant
11/26/2009	WO2009142978A1 Synthesis of polyesters with precisely sequenced two or more structural units
11/26/2009	WO2009142893A2 Methods and compositions for the delivery of bioactive compounds
11/26/2009	WO2009142852A2 Process for manufacturing flowable powder drug compositions
11/26/2009	WO2009142772A2 Methods and treatment for allergies and inflammation associated with gastrointestinal diseases
11/26/2009	WO2009142731A2 Niacin and nsaid combination therapy
11/26/2009	WO2009142719A2 Tympanic membrane permeating ear drops and uses thereof
11/26/2009	WO2009142672A2 Antimicrobial and odor adsorbing textile
11/26/2009	WO2009142421A2 Pharmaceutical preparation (pharmaceutical formulation)
11/26/2009	WO2009142366A1 Manufacturing method of thermo-rod for active drug release the thermo-rod
11/26/2009	WO2009142319A1 Vascular aging inhibitor and anti-aging formulation
11/26/2009	WO2009142275A1 Mousse-type oil-and-fat composition and process for production thereof
11/26/2009	WO2009142018A1 Method for producing vesicle, vesicle obtained by the production method, and w/o/w emulsion for producing vesicle
11/26/2009	WO2009141738A2 Modified drugs for use in liposomal nanoparticles
11/26/2009	WO2009141450A2 Liposomes for drug delivery and methods for preparation thereof
11/26/2009	WO2009141418A1 Formulations of peg-functionalised serine proteases with high concentrations of an aromatic preservative
11/26/2009	WO2009141388A1 Mucoadhesive particulate formulation for inducing antigen-specific immune tolerance
11/26/2009	WO2009141329A1 Polyelectrolyte-encapsulated gold nanoparticles capable of crossing blood-brain barrier
11/26/2009	WO2009141321A2 Tablettable chewing gums
11/26/2009	WO2009141309A1 Delivery system for paliperidone
11/26/2009	WO2009141257A1 Perfluorcarbon nanoemulsions with endocytosis enhancing surface for gene-transfer
11/26/2009	WO2009141239A1 A pharmaceutical formulation comprising an antibody against ox40l, uses thereof
11/26/2009	WO2009141116A1 Fosphenytoin composition
11/26/2009	WO2009140887A1 A scutellarin derivative, the preparing process, the pharmaceutical composition and the use thereof
11/26/2009	WO2009140886A1 A scutellarin derivative, the preparing process, the pharmaceutical composition and the use thereof
11/26/2009	WO2009122301A3 Rasagiline mesylate particles and process for the preparation thereof
11/26/2009	WO2009116764A3 Cell migration, cell infiltration, or neovascularization inhibitor through degradation of function of ptk7 protein
11/26/2009	WO2009112287A9 Process and apparatus for producing a tabletting aid and also a tabletting aid and tabletting mixture
11/26/2009	WO2009102443A3 Octanoic acid formulations and methods of treatment using the same
11/26/2009	WO2009101110A9 Method for manufacturing mesoporous materials, materials so produced and use of mesoporous materials
11/26/2009	WO2009100886A3 Formulations of flibanserin
11/26/2009	WO2009090439A3 Method for stabilization of s-nitrosoglutathione and composition prepared by the same
11/26/2009	WO2009087663A3 Oral controlled release coated tablet
11/26/2009	WO2009083211A3 Pharmaceutical compound for the prophylaxis and/or symptomatic treatment of cystic fibrosis
11/26/2009	WO2009079679A3 Pharmaceutical composition for the parenteral administration of ultrashort-effective beta-adrenoreceptor antagonists
11/26/2009	WO2009076236A3 Micronized opioid compositions, formulations and dosage forms and methods of making same
11/26/2009	WO2009071959A3 Composition containing itraconazole
11/26/2009	WO2009066182A4 Method of treating cancer
11/26/2009	WO2009058585A3 Non-aqueous water-miscible materials as vehicles for drug delivery
11/26/2009	WO2009047565A3 Zibotentan composition containing mannitol and/or microcrystalline cellulose
11/26/2009	WO2009026430A3 Liposome formulations of boronic acid compounds
11/26/2009	WO2009006095A3 Dual portion lozenge dosage form
11/26/2009	WO2008154234A9 Extended release formulation of nevirapine
11/26/2009	WO2008095597A3 Transdermal therapeutic system for administering water-soluble active ingredients
11/26/2009	WO2008094675A3 Novel biomaterials and methods for making and using same
11/26/2009	US20090292237 Modular Drug Delivery System for Minimizing Trauma During and After Insertion of a Cochlear Lead
11/26/2009	US20090292028 Menthol-containing formulation
11/26/2009	US20090292026 Treatment of CNS Disorders With trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine
11/26/2009	US20090292016 Stable Pharmaceutical Compositions Containing Pravastatin
11/26/2009	US20090291886 Transmucosal delivery of peptides and proteins
11/26/2009	US20090291146 Process for manufacturing lactose
11/26/2009	US20090291145 Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
11/26/2009	US20090291144 Therapeutic and Prophylactic Compositions Including Catalytic Biomimetic Solids and Methods to Prepare and Use Them
11/26/2009	US20090291143 Combination of Azelastine and Steroids
11/26/2009	US20090291142 Nanoparticulate bicalutamide formulations
11/26/2009	US20090291141 Method of quenching electronic excitation of chromophore-containing organic molecules in photoactive compositions

1 ... 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 ... 2991